Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

The Future of ITP Treatment

January 24th 2019

Rituximab and Salvage Therapies for Patients With ITP

January 24th 2019

TPO Duration of Response and Toxicity

January 24th 2019

TPO Receptor Agonist Selection and Patient Adherence

January 24th 2019

Romiplostim Classification and Mechanism of Action

January 24th 2019

Fostamatinib as Second-Line ITP Therapy

January 24th 2019

Second-Line Treatment Options for Patients with ITP

January 24th 2019

Steroid Combination Therapy & New ASH Guidelines

January 24th 2019

First-Line Therapy Options for Patients with ITP

January 24th 2019

ITP Patient Management and Important Treatment Factors

January 24th 2019

ITP Treatment Selection Criteria and Treatment Goals

January 24th 2019

ITP Pathogenesis, Presentation, and Diagnostic Workup

January 24th 2019

Future Treatment Strategies in Adult ALL

January 22nd 2019

Evaluating CAR T Therapy in Acute Lymphoblastic Leukemia

January 22nd 2019

When to Use Inotuzumab Ozogamicin for Adult ALL

January 22nd 2019

Selecting a Novel Therapy for Relapsed/Refractory ALL

January 22nd 2019

Allogeneic Transplant at First Remission of ALL

January 22nd 2019

Establishing MRD's Role in ALL Management

January 22nd 2019

Blinatumomab: Safety Data in Ph-Negative ALL

January 22nd 2019

Ph-Negative ALL: Establishing Blinatumomab's Role in Therapy

January 22nd 2019